Minimizing Relapse Risk in Psychosis

Introduction to Relapse Prevention

The British Journal of Psychiatry recommends continuous comprehensive biopsychosocial care with long-term antipsychotic medication, family psychoeducation, and early recognition of warning signs to minimize relapse risk in psychosis, as relapses are common during the first few years with vulnerability persisting in about 80% of patients 1, 2

Appropriate antipsychotic medication is the cornerstone of relapse prevention, with atypical antipsychotics preferred due to better tolerability and improved adherence 3, 2
Once psychosis has achieved sustained remission, slow reduction of antipsychotic medication should be attempted to determine minimal effective dose, but complete discontinuation significantly increases relapse risk 4, 5
Long-term medication is strongly advised for individuals who experience frequent relapses, with studies showing five times higher relapse rates among those who discontinue medication 2, 5
Consider long-acting injectable antipsychotics for patients with demonstrated non-adherence or recurrent relapses related to partial or full non-adherence 5

Early warning signs of relapse should be thoroughly discussed with both patient and family to enable prompt intervention 2, 6
Maintain vigilance for signs of relapse while simultaneously allowing space for recovery and normal development 2, 7
Regular monitoring for depression, suicide risk, substance misuse, and social anxiety is essential as these can trigger relapse 4, 6

Patients should remain in comprehensive, multidisciplinary, specialist mental healthcare throughout the early years of psychosis (critical period up to 5 years) 2, 6
Ensure continuity of care with treating clinicians remaining constant for at least the first 18 months of treatment 2, 8
Do not discharge patients to primary care without continuing specialist involvement once acute symptoms improve 2, 6

Families should be progressively informed and educated about psychosis, treatments, and expected outcomes 1, 3
For patients with frequent relapses or slow recovery, provide more intensive and prolonged psychoeducational interventions for families 1, 4
Multi-family groups with psychoeducation focus should be offered as they significantly reduce relapse rates 4, 6
Family therapy may be indicated when there is high distress in the family 1, 9

Psychological and psychosocial treatments should be core elements in treatment and used to assist resolution of symptoms and management of comorbidities 4
Supportive psychotherapy with active problem-solving orientation and assistance with occupational pursuits should be offered 2, 7
Recovery work should emphasize finding meaning and developing mastery in relation to the psychotic experience 4, 6
Regular monitoring and management of side effects (weight gain, sexual dysfunction, sedation) is essential as these can impact adherence and quality of life 4, 6

Reactive rather than preventive care approaches miss the best opportunity for enhancing outcomes 2, 6
Premature discharge from specialist services increases relapse risk 2, 6
Failing to monitor and address medication side effects can lead to non-adherence and subsequent relapse 4, 6